Holdings of Invesco Nasdaq Biotechnology ETF
Invesco Exchange-Traded Fund Trust II · Original filing · Compare with another fund · Report an error
- Net assets
- 67.4M $ including 67.3M $ in equities, 99.9 %
- Positions
- 254 in 18 countries
- Top ten
- 40.7 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | ABCELLERA BIOLOGICS INC | 16,253 | 100.3K $ | 0.15 % |
| 102 | Zymeworks Inc | 3,989 | 100.2K $ | 0.15 % |
| 103 | SAREPTA THERAPEUTICS INC | 5,587 | 99.8K $ | 0.15 % |
| 104 | Recursion Pharmaceuticals Inc | 27,806 | 99.8K $ | 0.15 % |
| 105 | Nurix Therapeutics Inc | 5,485 | 97.4K $ | 0.14 % |
| 106 | Harmony Biosciences Holdings Inc | 3,083 | 97.4K $ | 0.14 % |
| 107 | Trevi Therapeutics Inc | 6,830 | 96.6K $ | 0.14 % |
| 108 | Novavax Inc | 8,735 | 95.8K $ | 0.14 % |
| 109 | TYRA BIOSCIENCES INC | 2,861 | 95.6K $ | 0.14 % |
| 110 | uniQure NV | 3,340 | 95.3K $ | 0.14 % |
| 111 | Stoke Therapeutics Inc | 3,080 | 95.2K $ | 0.14 % |
| 112 | ANI Pharmaceuticals Inc | 1,202 | 94.4K $ | 0.14 % |
| 113 | Syndax Pharmaceuticals Inc | 4,729 | 92.6K $ | 0.14 % |
| 114 | Agios Pharmaceuticals Inc | 3,120 | 91.7K $ | 0.14 % |
| 115 | Genmab A/S | 3,433 | 90.4K $ | 0.13 % |
| 116 | Iovance Biotherapeutics Inc | 22,004 | 90.2K $ | 0.13 % |
| 117 | Vericel Corp | 2,703 | 90.1K $ | 0.13 % |
| 118 | Intellia Therapeutics Inc | 6,285 | 88.4K $ | 0.13 % |
| 119 | AtaiBeckley Inc | 19,357 | 87.7K $ | 0.13 % |
| 120 | Taysha Gene Therapies Inc | 14,607 | 85.7K $ | 0.13 % |
| 121 | Innoviva Inc | 3,971 | 85.1K $ | 0.13 % |
| 122 | AMYLYX PHARMACEUTICALS INC | 5,907 | 84.8K $ | 0.13 % |
| 123 | AnaptysBio Inc | 1,484 | 82.6K $ | 0.12 % |
| 124 | Precigen Inc | 18,903 | 82K $ | 0.12 % |
| 125 | Inhibrx Biosciences Inc | 777 | 80.8K $ | 0.12 % |
| 126 | Monte Rosa Therapeutics Inc | 4,064 | 80.1K $ | 0.12 % |
| 127 | Vir Biotechnology Inc | 8,374 | 79.9K $ | 0.12 % |
| 128 | Ardelyx Inc | 13,224 | 79.9K $ | 0.12 % |
| 129 | GH RESEARCH PLC | 3,325 | 79.8K $ | 0.12 % |
| 130 | Fortrea Holdings Inc | 5,013 | 77.2K $ | 0.11 % |
| 131 | MBX BIOSCIENCES INC | 2,407 | 75.7K $ | 0.11 % |
| 132 | KalVista Pharmaceuticals Inc | 2,736 | 73.5K $ | 0.11 % |
| 133 | Bicara Therapeutics Inc | 3,380 | 73.5K $ | 0.11 % |
| 134 | Septerna Inc | 2,373 | 71.7K $ | 0.11 % |
| 135 | UroGen Pharma Ltd | 2,509 | 70.6K $ | 0.10 % |
| 136 | Harrow Inc | 1,970 | 69.4K $ | 0.10 % |
| 137 | Maze Therapeutics Inc | 2,580 | 68.3K $ | 0.10 % |
| 138 | Immunocore Holdings PLC | 2,351 | 67.9K $ | 0.10 % |
| 139 | ArriVent Biopharma Inc | 2,201 | 66.6K $ | 0.10 % |
| 140 | WAVE LIFE SCIENCES LTD | 10,093 | 66.4K $ | 0.10 % |
| 141 | COMPASS PATHWAYS PLC | 5,056 | 66K $ | 0.10 % |
| 142 | Personalis Inc | 5,529 | 63K $ | 0.09 % |
| 143 | MannKind Corp | 16,518 | 62.3K $ | 0.09 % |
| 144 | EyePoint Inc | 4,438 | 60.3K $ | 0.09 % |
| 145 | Alvotech SA | 17,707 | 59.5K $ | 0.09 % |
| 146 | SAVARA INC | 10,908 | 56.7K $ | 0.08 % |
| 147 | Collegium Pharmaceutical Inc | 1,685 | 56.6K $ | 0.08 % |
| 148 | Olema Pharmaceuticals Inc | 4,281 | 56.5K $ | 0.08 % |
| 149 | Corvus Pharmaceuticals Inc | 4,427 | 54.9K $ | 0.08 % |
| 150 | Xeris Biopharma Holdings Inc | 8,895 | 54.8K $ | 0.08 % |
| 151 | Absci Corp | 8,106 | 54.7K $ | 0.08 % |
| 152 | ZENAS BIOPHARMA INC | 2,878 | 53K $ | 0.08 % |
| 153 | Cullinan Therapeutics Inc | 3,167 | 52.1K $ | 0.08 % |
| 154 | Grifols SA | 6,540 | 51.3K $ | 0.08 % |
| 155 | Pacira BioSciences Inc | 2,147 | 49.9K $ | 0.07 % |
| 156 | ARS Pharmaceuticals Inc | 5,331 | 48.4K $ | 0.07 % |
| 157 | Sana Biotechnology Inc | 14,370 | 47.4K $ | 0.07 % |
| 158 | Arbutus Biopharma Corp | 10,311 | 47K $ | 0.07 % |
| 159 | Kura Oncology Inc | 4,597 | 46.9K $ | 0.07 % |
| 160 | Janux Therapeutics Inc | 3,213 | 46.9K $ | 0.07 % |
| 161 | Xencor Inc | 3,932 | 46.7K $ | 0.07 % |
| 162 | MeiraGTx Holdings plc | 4,315 | 46K $ | 0.07 % |
| 163 | Amphastar Pharmaceuticals Inc | 2,430 | 45.8K $ | 0.07 % |
| 164 | ORIC Pharmaceuticals Inc | 5,304 | 44.8K $ | 0.07 % |
| 165 | Theravance Biopharma Inc | 2,717 | 43.6K $ | 0.06 % |
| 166 | Eton Pharmaceuticals Inc | 1,421 | 43.3K $ | 0.06 % |
| 167 | Geron Corp | 34,223 | 42.8K $ | 0.06 % |
| 168 | Mesoblast Ltd. | 2,767 | 42.6K $ | 0.06 % |
| 169 | Annexon Inc | 7,808 | 42.3K $ | 0.06 % |
| 170 | OMEROS CORP | 3,801 | 42K $ | 0.06 % |
| 171 | Phathom Pharmaceuticals Inc | 4,246 | 40.7K $ | 0.06 % |
| 172 | BioAge Labs Inc | 2,294 | 39.7K $ | 0.06 % |
| 173 | Esperion Therapeutics Inc | 12,603 | 39.4K $ | 0.06 % |
| 174 | Replimune Group Inc | 4,362 | 37.9K $ | 0.06 % |
| 175 | Maravai LifeSciences Holdings Inc | 7,725 | 37.1K $ | 0.06 % |
| 176 | CorMedix Inc | 4,165 | 35.2K $ | 0.05 % |
| 177 | Zevra Therapeutics Inc | 2,973 | 34.5K $ | 0.05 % |
| 178 | Phibro Animal Health Corp | 1,102 | 33.9K $ | 0.05 % |
| 179 | PRIME MEDICINE INC | 9,524 | 33.8K $ | 0.05 % |
| 180 | VOR BIOPHARMA INC | 2,243 | 33.6K $ | 0.05 % |
| 181 | Castle Biosciences Inc | 1,566 | 33K $ | 0.05 % |
| 182 | CYTOMX THERAPEUTICS INC | 8,930 | 32.1K $ | 0.05 % |
| 183 | Candel Therapeutics Inc | 3,866 | 32.1K $ | 0.05 % |
| 184 | ZAI LAB LTD | 1,809 | 32K $ | 0.05 % |
| 185 | Design Therapeutics Inc | 3,012 | 31.6K $ | 0.05 % |
| 186 | Tectonic Therapeutic Inc | 1,000 | 31.2K $ | 0.05 % |
| 187 | Ironwood Pharmaceuticals Inc | 8,601 | 30.7K $ | 0.05 % |
| 188 | Arvinas Inc | 3,371 | 30.3K $ | 0.04 % |
| 189 | Solid Biosciences Inc | 4,114 | 30.2K $ | 0.04 % |
| 190 | Rigel Pharmaceuticals Inc | 963 | 29.4K $ | 0.04 % |
| 191 | Aclaris Therapeutics Inc | 6,364 | 29K $ | 0.04 % |
| 192 | Prothena Corp PLC | 2,828 | 28.8K $ | 0.04 % |
| 193 | 4D Molecular Therapeutics Inc | 2,688 | 26.6K $ | 0.04 % |
| 194 | Aquestive Therapeutics Inc | 6,441 | 25.9K $ | 0.04 % |
| 195 | Kyverna Therapeutics Inc | 3,022 | 25.7K $ | 0.04 % |
| 196 | Allogene Therapeutics Inc | 11,864 | 25.7K $ | 0.04 % |
| 197 | Aura Biosciences Inc | 3,345 | 25K $ | 0.04 % |
| 198 | FULCRUM THERAPEUTICS INC | 3,501 | 24.2K $ | 0.04 % |
| 199 | Kamada Ltd | 3,054 | 23.9K $ | 0.04 % |
| 200 | Neurogene Inc | 839 | 23.8K $ | 0.04 % |
Sector breakdown
- Health care 46.5 %
- Unattributed 53.5 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 87.7 %
- Netherlands 2.5 %
- Ireland 1.9 %
- Bermuda 1.7 %
- France 1.5 %
- Denmark 1.2 %
- Germany 0.9 %
- Canada 0.7 %
- United Kingdom 0.5 %
- Switzerland 0.4 %
- Cayman Islands 0.3 %
- Jersey 0.2 %
- Other countries 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 217 | 59M $ | 87.65 % |
| 2 | Netherlands | 4 | 1.7M $ | 2.49 % |
| 3 | Ireland | 4 | 1.3M $ | 1.88 % |
| 4 | Bermuda | 1 | 1.2M $ | 1.71 % |
| 5 | France | 2 | 1M $ | 1.50 % |
| 6 | Denmark | 2 | 830.2K $ | 1.23 % |
| 7 | Germany | 1 | 586.4K $ | 0.87 % |
| 8 | Canada | 3 | 453.4K $ | 0.67 % |
| 9 | United Kingdom | 5 | 368.8K $ | 0.55 % |
| 10 | Switzerland | 2 | 302.7K $ | 0.45 % |
| 11 | Cayman Islands | 5 | 220.4K $ | 0.33 % |
| 12 | Jersey | 1 | 103.5K $ | 0.15 % |
Cite this page
Titelia. "Holdings of Invesco Nasdaq Biotechnology ETF". https://titelia.com/en/funds/S000072469